Suchergebnisse - "Brunetti, Oronzo"

PubPharm (175)

101

Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma : A case report and literature review

enthalten in: Clinical case reports | 2019

von Argentiero, A. | Calabrese, A. | Solimando, A. | +3

102

Immune System and Bone Microenvironment: Rationale for Targeted Cancer Therapies

enthalten in: Preprints.org | 2019

von Gnoni, A. | Brunetti, O. | Longo, V. | +4

103

Skeletal Metastases of Unknown Primary : Biological Landscape and Clinical Overview

enthalten in: Cancers | 2019

von Argentiero, A. | Solimando, A. | Brunetti, O. | +6

104

Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma: Could Surgery Represent a Therapeutic Option?

enthalten in: Preprints.org | 2019

von Argentiero, A. | Brunetti, O. | Calabrese, A. | +4

105

Management of targeted therapies in cancer patients with chronic kidney disease, or on haemodialysis : An Associazione Italiana di Oncologia Medica (AIOM)/Societa' Italiana di Nefrologia (SIN) multidisciplinary consensus position paper

enthalten in: Critical reviews in oncology/hematology | 2019

von Silvestris, N. | Argentiero, A. | Cosmai, L. | +8

106

The Italian Rare Pancreatic Exocrine Cancer Initiative

enthalten in: Tumori | 2019

von Brunetti, O. | Luchini, C. | Argentiero, A. | +26

ErratumIn: Tumori. 2020 Dec;106(6):526. - PMID 32172676

107

Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma : A Pilot Study

enthalten in: Cancers | 2019

von Argentiero, A. | De Summa, S. | Di Fonte, R. | +7

108

Predictive Factors of Response to Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumors (GISTs): A Multi-Institutional Study

enthalten in: Preprints.org | 2019

von Badalamenti, G. | Incorvaia, L. | Vincenzi, B. | +15

109

Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line Therapy

enthalten in: Cancers | 2019

von Brunetti, O. | Badalamenti, G. | De Summa, S. | +12

110

Inflammatory cells infiltrate and angiogenesis in locally advanced and metastatic cholangiocarcinoma

enthalten in: European journal of clinical investigation | 2019

von Tamma, R. | Annese, T. | Ruggieri, S. | +7